<table><tr><td>510(k) Owner:</td><td>Contact: Hyman Katz, Ph.D. Phone: 973-852-0158</td><td colspan="2">Alfa Wassermann Diagnostic Technologies, LLC 4 Henderson Drive West Caldwell, NJ 07006 Hkatz@AlfaWassermannUS.com AUG 1 9 2013</td></tr><tr><td>Date Summary Prepared: Device:</td><td>Fax: July 12, 2013</td><td>973-852-0237</td><td></td></tr><tr><td></td><td>Trade Name: Classification: Common/Classification Name:</td><td>ACE Albumin Reagent Class 2 (21 C.F.R. § 862.1035) Product Code CIX</td><td>Bromcresol Green Dye-Binding, Albumin</td></tr><tr><td></td><td>Trade Name: Classification: Common/Classification Name:</td><td>ACE Total Protein Reagent Class 2 Biuret (Colorimetric), Total Protein</td><td></td></tr><tr><td></td><td></td><td>(21 C.F.R. § 862.1635) Product Code CEK</td><td></td></tr><tr><td></td><td>Trade Name: Classification: Common/Classification Name:</td><td>ACE Calcium-Arsenazo Reagent</td><td></td></tr><tr><td></td><td></td><td>Class 2 Azo Dye, Calcium</td><td></td></tr><tr><td></td><td></td><td>Product Code CJY</td><td>(21 C.F.R. § 862.1445)</td></tr><tr><td></td><td>Trade Name:</td><td></td><td></td></tr><tr><td></td><td>Classification: Common/Classification Name:</td><td>Class 1</td><td>ACE Inorganic Phosphorus U.V. Reagent</td></tr><tr><td>Predicate Manufacturer for reagent system predicates: Devices:</td><td></td><td>Phosphorus</td><td>Phosphomolybdate (Colorimetric), Inorganic</td></tr></table>

<table><tr><td>Device Descriptions: the sample.</td><td>In the ACE Albumin Reagent assay, Bromcresol green binds specifically to albumin to form a green colored complex, which is measured bichromatically at 629 nm/692 nm. The intensity of color produced is directly proportional to the albumin concentration in</td></tr><tr><td></td><td>In the ACE Total Protein Reagent assay, cupric ions react with the peptide bonds of proteins under alkaline conditions to form a violet colored complex, which is measured bichromatically at 544 nm/692 nm. The intensity of color produced is directly proportional to the total protein concentration in the sample. In the ACE Calcium-Arsenazo Reagent assay, calcium reacts with Arsenazo III in an acidic solution to form a blue-purple colored complex, which is measured bichromatically at 647 nm/692 nm. The intensity of color produced is directly proportional to the calcium concentration in the sample. In the ACE Inorganic Phosphorus U.V. Reagent assay, under acidic conditions, inorganic phosphorus in serum reacts with ammonium molybdate to form an unreduced phosphomolybdate complex, which absorbs strongly at 340 nm. The increase in absorbance, measured bichromatically at 340 nm/378 nm, is directly proportional to the</td></tr><tr><td>Intended Use: for use in clinical laboratories or physician office laboratories. For in vitro diagnostic use only.</td><td>amount of phosphorus in the sample. Indications for Use: ACE Albumin Reagent is intended for the quantitative determination of albumin concentration in serum and lithium heparin plasma using the ACE, ACE Alera, and ACE Axcel Clinical Chemistry Systems. Albumin measurements are used in the diagnosis and treatment of numerous diseases involving primarily the liver or kidneys. This test is intended for use in clinical laboratories or physician office laboratories. For in vilro diagnostic use only. ACE Total Protein Reagent is intended for the quantitative determination of total protein concentration in serum and lithium heparin plasma using the ACE, ACE Alera, and ACE Axcel Clinical Chemistry Systems. Total protein measurements are used in the diagnosis and treatment of a variety of diseases involving the liver, kidney, or bone marrow as well as other metabolic or nutritional disorders. This test is intended for use in clinical laboratories or physician office laboratories. For in vitro diagnostic use only. ACE Calcium-Arsenazo Reagent is intended for the quantitative determination of calcium concentration in serum and lithium heparin plasma using the ACE, ACE Alera, and ACE Axcel Clinical Chemistry Systems. Calcium measurements are used in the diagnosis and treatment of parathyroid disease, a variety of bone diseases, chronic renal disease and tetany (intermittent muscular contractions or spasms). This test is intended</td></tr><tr><td></td><td>ACE Inorganic Phosphorus U.V. Reagent is intended for the quantitative determination of inorganic phosphorus concentration in serum and lithium heparin plasma using the ACE, ACE Alera, and ACE Axcel Clinical Chemistry Systems. Measurements of inorganic phosphorus are used in the diagnosis and treatment of various disorders, including parathyroid gland and kidney diseases and vitamin D imbalance. This test is intended for use in clinical laboratories or physician office laboratories. For in vitro diagnostic use only.</td></tr><tr><td>Technological Characteristics:</td><td>ACE Albumin Reagent consists of a single reagent bottle. The reagent contains Bromcresol green and acetate buffer. ACE Total Protein Reagent consists of a single reagent bottle. The reagent contains copper sulfate, sodium potassium tartrate, potassium iodide and sodium hydroxide. ACE Calcium-Arsenazo Reagent consists of a single reagent bottle. The Reagent contains Arsenazo III. ACE Inorganic Phosphorus U.V. Reagent consists of a single reagent bottle. The reagent contains ammonium molybdate and sulfuric acid.</td></tr></table>

Device Comparison with Predicate   

<table><tr><td rowspan=1 colspan=3>Comparison of similarities and differences with predicate deviceACE Albumin Reagent</td></tr><tr><td rowspan=1 colspan=1>ALB</td><td rowspan=1 colspan=1>Candidate Device</td><td rowspan=1 colspan=1>Predicate DeviceK930104(ACE ALB)</td></tr><tr><td rowspan=1 colspan=1>Intended Use/Indications for Use</td><td rowspan=1 colspan=1>The ACE Albumin Reagent is intendedfor the quantitative determination ofalbumin concentration.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Platforms</td><td rowspan=1 colspan=1>ACE, ACE Alera®, and ACE AxcelClinical Chemistry Systems</td><td rowspan=1 colspan=1>ACE Clinical Chemistry System</td></tr><tr><td rowspan=1 colspan=1>Method</td><td rowspan=1 colspan=1>Photometric</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>CalibrationStability</td><td rowspan=1 colspan=1>30 days</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>On-Board Stability</td><td rowspan=1 colspan=1>30 Days</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Sample Type</td><td rowspan=1 colspan=1>Serum and lithium heparin plasma</td><td rowspan=1 colspan=1>Serum</td></tr><tr><td rowspan=1 colspan=1>Sample Volume</td><td rowspan=1 colspan=1>3μL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Reaction Volume</td><td rowspan=1 colspan=1>463 μL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Expected Values</td><td rowspan=1 colspan=1>3.5 - 5.2 g/dL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Measuring Range</td><td rowspan=1 colspan=1>0.1 - 7.6 g/dL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Sample Stability</td><td rowspan=1 colspan=1>Specimen stable at 4°C for up to 72 hoursand frozen at -20°C for 6 months orindefinitely at -70°C.</td><td rowspan=1 colspan=1>Same</td></tr></table>

# ACE Total Protein Reagent

<table><tr><td rowspan=1 colspan=1>Total Protein</td><td rowspan=1 colspan=1>Candidate Device</td><td rowspan=1 colspan=1>Predicate DeviceK930104(ACE Total Protein)</td></tr><tr><td rowspan=1 colspan=1>Intended Use/Indications for Use</td><td rowspan=1 colspan=1>The ACE Total Protein Reagent isintended for the quantitativedetermination of total proteinconcentration.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Platforms</td><td rowspan=1 colspan=1>ACE, ACE Alera®, and ACE AxcelClinical Chemistry Systems</td><td rowspan=1 colspan=1>ACE Clinical Chemistry System</td></tr><tr><td rowspan=1 colspan=1>Method</td><td rowspan=1 colspan=1>Photometric</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>CalibrationStability</td><td rowspan=1 colspan=1>30 Days</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>On-Board Stability</td><td rowspan=1 colspan=1>30 Days</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Sample Type</td><td rowspan=1 colspan=1>Serum and lithium heparin plasma</td><td rowspan=1 colspan=1>Serum</td></tr><tr><td rowspan=1 colspan=1>Sample Volume</td><td rowspan=1 colspan=1>3μL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Reaction Volume</td><td rowspan=1 colspan=1>218 μL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Expected Values</td><td rowspan=1 colspan=1>6.0-8.3 g/dL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Measuring Range</td><td rowspan=1 colspan=1>0.2- 15.1 g/dL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Sample Stability</td><td rowspan=1 colspan=1>Specimen stable at 4°C for up to 72 hoursand frozen at -20°C for 6 months orindefinitely at -70°C.</td><td rowspan=1 colspan=1>Same</td></tr></table>

<table><tr><td rowspan=13 colspan=1>DeviceComparisonwith Predicate</td><td rowspan=1 colspan=3>ACE Calcium-Arsenazo Reagent</td></tr><tr><td rowspan=1 colspan=1>Calcium-Arsenazo</td><td rowspan=1 colspan=1>Candidate Device</td><td rowspan=1 colspan=1>Predicate DeviceK930104(ACE Calcium-Arsenazo)</td></tr><tr><td rowspan=1 colspan=1>Intended Use/Indications for Use</td><td rowspan=1 colspan=1>ACE Calcium-Arsenazo Reagent isintended for the quantitativedetermination of calcium.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Platforms</td><td rowspan=1 colspan=1>ACE, ACE Alera*, and ACE AxcelClinical Chemistry Systems</td><td rowspan=1 colspan=1>ACE Clinical Chemistry System</td></tr><tr><td rowspan=1 colspan=1>Method</td><td rowspan=1 colspan=1>Photometric</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>CalibrationStability</td><td rowspan=1 colspan=1>30 Days</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>On-Board Stability</td><td rowspan=1 colspan=1>30 Days</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Sample Type</td><td rowspan=1 colspan=1>Serum and lithium heparin plasma</td><td rowspan=1 colspan=1>Serum</td></tr><tr><td rowspan=1 colspan=1>Sample Volume</td><td rowspan=1 colspan=1>3μL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Reaction Volume</td><td rowspan=1 colspan=1>318μL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Expected Values</td><td rowspan=1 colspan=1>8.5 - 10.2 mg/dL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Measuring Range</td><td rowspan=1 colspan=1>0.2 - 16.5 mg/dL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Sample Stability</td><td rowspan=1 colspan=1>Specimen stable for 7 days at 20-25°C, 3weeks at 4-8°C, and 8 months at -20°C</td><td rowspan=1 colspan=1>Same</td></tr></table>

ACE Inorganic Phosphorus U.V. Reagent   

<table><tr><td rowspan=1 colspan=1>InorganicPhosphorus</td><td rowspan=1 colspan=1>Candidate Device</td><td rowspan=1 colspan=1>Predicate DeviceK930104(ACE Inorganic Phosphorus)</td></tr><tr><td rowspan=1 colspan=1>Intended Use/Indications for Use</td><td rowspan=1 colspan=1>ACE Inorganic Phosphorus U.V.Reagent is intended for thequantitative determination ofinorganic phosphorus.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Platforms</td><td rowspan=1 colspan=1>ACE, ACE Alera®, and ACE AxcelClinical Chemistry Systems</td><td rowspan=1 colspan=1>ACE Clinical Chemistry System</td></tr><tr><td rowspan=1 colspan=1>Method</td><td rowspan=1 colspan=1>Photometric</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Calibration Stability</td><td rowspan=1 colspan=1>30 Days</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>On-Board Stability</td><td rowspan=1 colspan=1>30 Days</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Sample Type</td><td rowspan=1 colspan=1>Serum and lithium heparin plasma</td><td rowspan=1 colspan=1>Serum</td></tr><tr><td rowspan=1 colspan=1>Sample Volume</td><td rowspan=1 colspan=1>3 μL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Reaction Volume</td><td rowspan=1 colspan=1>218 μL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Expected Values</td><td rowspan=1 colspan=1>2.7 - 4.5 mg/dL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Measuring Range</td><td rowspan=1 colspan=1>0.4 - 21 mg/dL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Sample Stability</td><td rowspan=1 colspan=1>Specimen stable for 4 days at 4-8°Cand for 1 year at -20°C.</td><td rowspan=1 colspan=1>Same</td></tr></table>

# Performance data for the Alfa Wassermann ACE Reagents run on the Alfa Wassermann ACE, ACE Alera and ACE Axcel Clinical Chemistry Systems

In-House Precision: Serum vs. Plasma $-$ ACE Albumin Reagent

Precision (SD, %CV)   
In-House Precision: Serum vs. Plasma - ACE Total Protein Reagent   

<table><tr><td rowspan=1 colspan=1>Albuming/dL</td><td rowspan=1 colspan=1>ACEMean</td><td rowspan=1 colspan=1>Within-Run</td><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>AleraMean</td><td rowspan=1 colspan=1>Within-Run</td><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>AxcelMean</td><td rowspan=1 colspan=1>Within-Run</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>Serum Low</td><td rowspan=1 colspan=1>4.1</td><td rowspan=1 colspan=1>0.05, 1.3%</td><td rowspan=1 colspan=1>0.07, 1.6%</td><td rowspan=1 colspan=1>4.1</td><td rowspan=1 colspan=1>0.04, 0.9%</td><td rowspan=1 colspan=1>0.04, 1.1%</td><td rowspan=1 colspan=1>4.1</td><td rowspan=1 colspan=1>0.02, 0.5%</td><td rowspan=1 colspan=1>0.04, 1.0%</td></tr><tr><td rowspan=1 colspan=1>Plasma Low</td><td rowspan=1 colspan=1>3.8</td><td rowspan=1 colspan=1>0.06, 1.7%</td><td rowspan=1 colspan=1>0.06, 1.7%</td><td rowspan=1 colspan=1>3.7</td><td rowspan=1 colspan=1>0.03, 0.8%</td><td rowspan=1 colspan=1>0.05, 1.4%</td><td rowspan=1 colspan=1>3.7</td><td rowspan=1 colspan=1>0.06, 1.6%</td><td rowspan=1 colspan=1>0.06, 1.6%</td></tr><tr><td rowspan=1 colspan=1>Serum Mid</td><td rowspan=1 colspan=1>5.4</td><td rowspan=1 colspan=1>0.08, 1.6%</td><td rowspan=1 colspan=1>0.10, 1.8%</td><td rowspan=1 colspan=1>5.3</td><td rowspan=1 colspan=1>0.05, 1.0%</td><td rowspan=1 colspan=1>0.06, 1.1%</td><td rowspan=1 colspan=1>5.3</td><td rowspan=1 colspan=1>0.03, 0.6%</td><td rowspan=1 colspan=1>0.03, 0.6%</td></tr><tr><td rowspan=1 colspan=1>Plasma Mid</td><td rowspan=1 colspan=1>5.0</td><td rowspan=1 colspan=1>0.05, 1.0%</td><td rowspan=1 colspan=1>0.07, 1.4%</td><td rowspan=1 colspan=1>5.0</td><td rowspan=1 colspan=1>0.08, 1.7%</td><td rowspan=1 colspan=1>0.08, 1.7%</td><td rowspan=1 colspan=1>4.9</td><td rowspan=1 colspan=1>0.04, 0.9%</td><td rowspan=1 colspan=1>0.05, 1.1%</td></tr><tr><td rowspan=1 colspan=1>Serum High</td><td rowspan=1 colspan=1>6.5</td><td rowspan=1 colspan=1>0.07, 1.1%</td><td rowspan=1 colspan=1>0.11, 1.6%</td><td rowspan=1 colspan=1>6.5</td><td rowspan=1 colspan=1>0.05, 0.8%</td><td rowspan=1 colspan=1>0.08, 1.3%</td><td rowspan=1 colspan=1>6.4</td><td rowspan=1 colspan=1>0.06, 1.0%</td><td rowspan=1 colspan=1>0.09, 1.3%</td></tr><tr><td rowspan=1 colspan=1>Plasma High</td><td rowspan=1 colspan=1>6.2</td><td rowspan=1 colspan=1>0.09, 1.5%</td><td rowspan=1 colspan=1>0.10, 1.7%</td><td rowspan=1 colspan=1>6.1</td><td rowspan=1 colspan=1>0.08, 1.3%</td><td rowspan=1 colspan=1>0.10, 1.6%</td><td rowspan=1 colspan=1>6.1</td><td rowspan=1 colspan=1>0.05, 0.9%</td><td rowspan=1 colspan=1>0.08, 1.3%</td></tr></table>

Precision (SD, %CV)   
In-House Precision: Serum vs. Plasma - ACE Calcium-Arsenazo Reagent   

<table><tr><td rowspan=1 colspan=1>TotalProteing/dL</td><td rowspan=1 colspan=1>ACEMean</td><td rowspan=1 colspan=1>Within-Run</td><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>AleraMean</td><td rowspan=1 colspan=1>Within-Run</td><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>AxcelMean</td><td rowspan=1 colspan=1>Within-Run</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>Serum Low</td><td rowspan=1 colspan=1>6.7</td><td rowspan=1 colspan=1>0.06, 1.0%</td><td rowspan=1 colspan=1>0.07, 1.0%</td><td rowspan=1 colspan=1>6.7</td><td rowspan=1 colspan=1>0.05, 0.7%</td><td rowspan=1 colspan=1>0.05,0.8%</td><td rowspan=1 colspan=1>6.8</td><td rowspan=1 colspan=1>0.08, 1.1%</td><td rowspan=1 colspan=1>0.09, 1.3%</td></tr><tr><td rowspan=1 colspan=1>Plasma Low</td><td rowspan=1 colspan=1>7.2</td><td rowspan=1 colspan=1>0.06, 0.9%</td><td rowspan=1 colspan=1>0.06, 0.9%</td><td rowspan=1 colspan=1>7.1</td><td rowspan=1 colspan=1>0.08, 1.1%</td><td rowspan=1 colspan=1>0.09, 1.2%</td><td rowspan=1 colspan=1>7.2</td><td rowspan=1 colspan=1>0.05, 0.8%</td><td rowspan=1 colspan=1>0.07, 0.9%</td></tr><tr><td rowspan=1 colspan=1>Serum Mid</td><td rowspan=1 colspan=1>8.4</td><td rowspan=1 colspan=1>0.11, 1.3%</td><td rowspan=1 colspan=1>0.11, 1.3%</td><td rowspan=1 colspan=1>8.4</td><td rowspan=1 colspan=1>0.08, 1.0%</td><td rowspan=1 colspan=1>0.08, 1.0%</td><td rowspan=1 colspan=1>8.4</td><td rowspan=1 colspan=1>0.07, 0.8%</td><td rowspan=1 colspan=1>0.11, 1.4%</td></tr><tr><td rowspan=1 colspan=1>Plasma Mid</td><td rowspan=1 colspan=1>8.8</td><td rowspan=1 colspan=1>0.04, 0.5%</td><td rowspan=1 colspan=1>0.06, 0.7%</td><td rowspan=1 colspan=1>8.7</td><td rowspan=1 colspan=1>0.06, 0.7%</td><td rowspan=1 colspan=1>0.1, 1.2%</td><td rowspan=1 colspan=1>8.8</td><td rowspan=1 colspan=1>0.07,0.8%</td><td rowspan=1 colspan=1>0.08, 0.9%</td></tr><tr><td rowspan=1 colspan=1>Serum High</td><td rowspan=1 colspan=1>10.1</td><td rowspan=1 colspan=1>0.07, 0.7%</td><td rowspan=1 colspan=1>0.08, 0.8%</td><td rowspan=1 colspan=1>10.0</td><td rowspan=1 colspan=1>0.07,0.7%</td><td rowspan=1 colspan=1>0.09, 0.9%</td><td rowspan=1 colspan=1>10.1</td><td rowspan=1 colspan=1>0.07,0.7%</td><td rowspan=1 colspan=1>0.09, 0.9%</td></tr><tr><td rowspan=1 colspan=1>Plasma High</td><td rowspan=1 colspan=1>10.3</td><td rowspan=1 colspan=1>0.13, 1.3%</td><td rowspan=1 colspan=1>0.14, 1.4%</td><td rowspan=1 colspan=1>10.2</td><td rowspan=1 colspan=1>0.11, 1.1%</td><td rowspan=1 colspan=1>0.14, 1.3%</td><td rowspan=1 colspan=1>10.4</td><td rowspan=1 colspan=1>0.08, 0.8%</td><td rowspan=1 colspan=1>0.10, 1.0%</td></tr></table>

Precision (SD, %CV)   

<table><tr><td colspan="1" rowspan="1">Calcium-Arsenazomg/dL</td><td colspan="1" rowspan="1">ACEMean</td><td colspan="1" rowspan="1">Within-Run</td><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">AleraMean</td><td colspan="1" rowspan="1">Within-Run</td><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">AxcelMean</td><td colspan="1" rowspan="1">Within-Run</td><td colspan="1" rowspan="1">Total</td></tr><tr><td colspan="1" rowspan="1">Serum Low</td><td colspan="1" rowspan="1">9.3</td><td colspan="1" rowspan="1">0.12, 1.3%</td><td colspan="1" rowspan="1">0.25, 2.7%</td><td colspan="1" rowspan="1">9.3</td><td colspan="1" rowspan="1">0.09, 0.9%</td><td colspan="1" rowspan="1">0.22, 2.4%</td><td colspan="1" rowspan="1">9.3</td><td colspan="1" rowspan="1">0.08, 0.8%</td><td colspan="1" rowspan="1">0.17,1.8%</td></tr><tr><td colspan="1" rowspan="1">Plasma Low</td><td colspan="1" rowspan="1">8.4</td><td colspan="1" rowspan="1">0.04, 0.5%</td><td colspan="1" rowspan="1">0.2,2.4%</td><td colspan="1" rowspan="1">8.3</td><td colspan="1" rowspan="1">0.10, 1.2%</td><td colspan="1" rowspan="1">0.17,2.0%</td><td colspan="1" rowspan="1">8.3</td><td colspan="1" rowspan="1">0.08, 0.9%</td><td colspan="1" rowspan="1">0.11, 1.4%</td></tr><tr><td colspan="1" rowspan="1">Serum Mid</td><td colspan="1" rowspan="1">11.7</td><td colspan="1" rowspan="1">0.18, 1.6%</td><td colspan="1" rowspan="1">0.2, 1.7%</td><td colspan="1" rowspan="1">11.6</td><td colspan="1" rowspan="1">0.14, 1.2%</td><td colspan="1" rowspan="1">0.14, 1.2%</td><td colspan="1" rowspan="1">11.6</td><td colspan="1" rowspan="1">0.1, 0.9%</td><td colspan="1" rowspan="1">0.11,0.9%</td></tr><tr><td colspan="1" rowspan="1">Plasma Mid</td><td colspan="1" rowspan="1">10.7</td><td colspan="1" rowspan="1">0.19,1.7%</td><td colspan="1" rowspan="1">0.20,1.9%</td><td colspan="1" rowspan="1">10.7</td><td colspan="1" rowspan="1">0.13, 1.2%</td><td colspan="1" rowspan="1">0.15, 1.4%</td><td colspan="1" rowspan="1">10.7</td><td colspan="1" rowspan="1">0.12, 1.2%</td><td colspan="1" rowspan="1">0.13,1.2%</td></tr><tr><td colspan="1" rowspan="1">Serum High</td><td colspan="1" rowspan="1">13.9</td><td colspan="1" rowspan="1">0.20, 1.4%</td><td colspan="1" rowspan="1">0.2, 1.4%</td><td colspan="1" rowspan="1">13.8</td><td colspan="1" rowspan="1">0.19, 1.4%</td><td colspan="1" rowspan="1">0.19,1.4%</td><td colspan="1" rowspan="1">13.8</td><td colspan="1" rowspan="1">0.09, 0.7%</td><td colspan="1" rowspan="1">0.11, 0.8%</td></tr><tr><td colspan="1" rowspan="1">Plasma High</td><td colspan="1" rowspan="1">13.0</td><td colspan="1" rowspan="1">0.25, 1.9%</td><td colspan="1" rowspan="1">0.26, 2.0%</td><td colspan="1" rowspan="1">12.9</td><td colspan="1" rowspan="1">0.13, 1.0%</td><td colspan="1" rowspan="1">0.14, 1.1%</td><td colspan="1" rowspan="1">13.1</td><td colspan="1" rowspan="1">0.15, 1.2%</td><td colspan="1" rowspan="1">0.18, 1.4%</td></tr><tr><td colspan="10" rowspan="1">In-House Precision: Serum vs. Plasma - ACE Inorganic Phosphorus ReagentPrecision (SD, %CV)</td></tr><tr><td colspan="1" rowspan="1">InorganicPhosphorusU.V.mg/dL</td><td colspan="1" rowspan="1">ACEMean</td><td colspan="1" rowspan="1">Within-Run</td><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">AleraMean</td><td colspan="1" rowspan="1">Within-Run</td><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">AxcelMean</td><td colspan="1" rowspan="1">Within-Run</td><td colspan="1" rowspan="1">Total</td></tr><tr><td colspan="1" rowspan="1">Serum Low</td><td colspan="1" rowspan="1">3.5</td><td colspan="1" rowspan="1">0.15,4.4%</td><td colspan="1" rowspan="1">0.17,5.0%</td><td colspan="1" rowspan="1">3.4</td><td colspan="1" rowspan="1">0.11, 3.1%</td><td colspan="1" rowspan="1">0.14,4.0%</td><td colspan="1" rowspan="1">3.5</td><td colspan="1" rowspan="1">0.11, 3.1%</td><td colspan="1" rowspan="1">0.14,4.1%</td></tr><tr><td colspan="1" rowspan="1">Plasma Low</td><td colspan="1" rowspan="1">3.1</td><td colspan="1" rowspan="1">0.16,5.1%</td><td colspan="1" rowspan="1">0.18,5.9%</td><td colspan="1" rowspan="1">3.0</td><td colspan="1" rowspan="1">0.11, 3.7%</td><td colspan="1" rowspan="1">0.15,5.0%</td><td colspan="1" rowspan="1">3.1</td><td colspan="1" rowspan="1">0.15,5.0%</td><td colspan="1" rowspan="1">0.19,6.1%</td></tr><tr><td colspan="1" rowspan="1">Serum Mid</td><td colspan="1" rowspan="1">10.2</td><td colspan="1" rowspan="1">0.04,0.3%</td><td colspan="1" rowspan="1">0.05, 0.5%</td><td colspan="1" rowspan="1">9.9</td><td colspan="1" rowspan="1">0.08,0.8%</td><td colspan="1" rowspan="1">0.08, 0.8%</td><td colspan="1" rowspan="1">10.2</td><td colspan="1" rowspan="1">0.04,0.4%</td><td colspan="1" rowspan="1">0.12, 1.2%</td></tr><tr><td colspan="1" rowspan="1">Plasma Mid</td><td colspan="1" rowspan="1">9.8</td><td colspan="1" rowspan="1">0.09,0.9%</td><td colspan="1" rowspan="1">0.09, 0.9%</td><td colspan="1" rowspan="1">9.6</td><td colspan="1" rowspan="1">0.07,0.8%</td><td colspan="1" rowspan="1">0.08,0.8%</td><td colspan="1" rowspan="1">9.9</td><td colspan="1" rowspan="1">0.06, 0.6%</td><td colspan="1" rowspan="1">0.12, 1.2%</td></tr><tr><td colspan="1" rowspan="1">Serum High</td><td colspan="1" rowspan="1">17.0</td><td colspan="1" rowspan="1">0.26, 1.5%</td><td colspan="1" rowspan="1">0.26, 1.6%</td><td colspan="1" rowspan="1">16.6</td><td colspan="1" rowspan="1">0.22, 1.3%</td><td colspan="1" rowspan="1">0.22, 1.3%</td><td colspan="1" rowspan="1">17.3</td><td colspan="1" rowspan="1">0.28, 1.6%</td><td colspan="1" rowspan="1">0.30, 1.7%</td></tr><tr><td colspan="1" rowspan="1">Plasma High</td><td colspan="1" rowspan="1">16.7</td><td colspan="1" rowspan="1">0.23, 1.4%</td><td colspan="1" rowspan="1">0.24, 1.4%</td><td colspan="1" rowspan="1">16.3</td><td colspan="1" rowspan="1">0.24, 1.5%</td><td colspan="1" rowspan="1">0.29, 1.8%</td><td colspan="1" rowspan="1">16.9</td><td colspan="1" rowspan="1">0.30,1.8%</td><td colspan="1" rowspan="1">0.32. 1.9%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>mg/dL</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Run</td><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Run</td><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Run</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>Serum Low</td><td rowspan=1 colspan=1>3.5</td><td rowspan=1 colspan=1>0.15,4.4%</td><td rowspan=1 colspan=1>0.17,5.0%</td><td rowspan=1 colspan=1>3.4</td><td rowspan=1 colspan=1>0.11, 3.1%</td><td rowspan=1 colspan=1>0.14,4.0%</td><td rowspan=1 colspan=1>3.5</td><td rowspan=1 colspan=1>0.11, 3.1%</td><td rowspan=1 colspan=1>0.14,4.1%</td></tr><tr><td rowspan=1 colspan=1>Plasma Low</td><td rowspan=1 colspan=1>3.1</td><td rowspan=1 colspan=1>0.16, 5.1%</td><td rowspan=1 colspan=1>0.18, 5.9%</td><td rowspan=1 colspan=1>3.0</td><td rowspan=1 colspan=1>0.11, 3.7%</td><td rowspan=1 colspan=1>0.15,5.0%</td><td rowspan=1 colspan=1>3.1</td><td rowspan=1 colspan=1>0.15,5.0%</td><td rowspan=1 colspan=1>0.19,6.1%</td></tr><tr><td rowspan=1 colspan=1>Serum Mid</td><td rowspan=1 colspan=1>10.2</td><td rowspan=1 colspan=1>0.04, 0.3%</td><td rowspan=1 colspan=1>0.05, 0.5%</td><td rowspan=1 colspan=1>9.9</td><td rowspan=1 colspan=1>0.08,0.8%</td><td rowspan=1 colspan=1>0.08, 0.8%</td><td rowspan=1 colspan=1>10.2</td><td rowspan=1 colspan=1>0.04, 0.4%</td><td rowspan=1 colspan=1>0.12, 1.2%</td></tr><tr><td rowspan=1 colspan=1>Plasma Mid</td><td rowspan=1 colspan=1>9.8</td><td rowspan=1 colspan=1>0.09, 0.9%</td><td rowspan=1 colspan=1>0.09, 0.9%</td><td rowspan=1 colspan=1>9.6</td><td rowspan=1 colspan=1>0.07, 0.8%</td><td rowspan=1 colspan=1>0.08,0.8%</td><td rowspan=1 colspan=1>9.9</td><td rowspan=1 colspan=1>0.06, 0.6%</td><td rowspan=1 colspan=1>0.12, 1.2%</td></tr><tr><td rowspan=1 colspan=1>Serum High</td><td rowspan=1 colspan=1>17.0</td><td rowspan=1 colspan=1>0.26, 1.5%</td><td rowspan=1 colspan=1>0.26, 1.6%</td><td rowspan=1 colspan=1>16.6</td><td rowspan=1 colspan=1>0.22, 1.3%</td><td rowspan=1 colspan=1>0.22, 1.3%</td><td rowspan=1 colspan=1>17.3</td><td rowspan=1 colspan=1>0.28, 1.6%</td><td rowspan=1 colspan=1>0.30, 1.7%</td></tr><tr><td rowspan=1 colspan=1>Plasma High</td><td rowspan=1 colspan=1>16.7</td><td rowspan=1 colspan=1>0.23, 1.4%</td><td rowspan=1 colspan=1>0.24, 1.4%</td><td rowspan=1 colspan=1>16.3</td><td rowspan=1 colspan=1>0.24, 1.5%</td><td rowspan=1 colspan=1>0.29, 1.8%</td><td rowspan=1 colspan=1>16.9</td><td rowspan=1 colspan=1>0.30, 1.8%</td><td rowspan=1 colspan=1>0.32. 1.9%</td></tr></table>

Performance Data:

In-House Precision - Serum vs. Plasma

Performance data for the Alfa Wassermann ACE Reagents run on the Alfa Wassermann ACE, ACE Alera and ACE Axcel Clinical Chemistry Systems   
In-House Matrix Comparison: Serum vs. Plasma $=$ ACE Albumin Reagent   

<table><tr><td>System</td><td>Range</td><td colspan="2">Results - Serum vs. Plasma</td></tr><tr><td>ACE</td><td rowspan="6">0.3-6.8 g/dL</td><td>Slope:</td><td>0.991</td></tr><tr><td rowspan="5">55 pairs</td><td>Intercept:</td><td>0.03</td></tr><tr><td>Correlation:</td><td>0.9874</td></tr><tr><td>Std. Error Est:</td><td>0.19</td></tr><tr><td>Confidence Interval Slope:</td><td>0.948 to 1.034</td></tr><tr><td>Confidence Interval Intercept:</td><td>-0.15 to 0.20</td></tr><tr><td rowspan="6">ACE Alera</td><td rowspan="6">0.3-6.8 g/dL</td><td>Slope:</td><td>1.002</td></tr><tr><td>Intercept:</td><td>-0.01</td></tr><tr><td>Correlation:</td><td>0.9905</td></tr><tr><td>Std. Error Est:</td><td>0.17</td></tr><tr><td>Confidence Interval Slope:</td><td>0.964 to 1.040</td></tr><tr><td>Confidence Interval Intercept:</td><td>-0.15 to 0.14</td></tr><tr><td rowspan="6">ACE Axcel 56 pairs</td><td rowspan="6">0.7-6.7 g/dL</td><td>Slope:</td><td>0.956</td></tr><tr><td>Intercept:</td><td>0.20</td></tr><tr><td>Correlation:</td><td>0.9850</td></tr><tr><td>Std. Error Est:</td><td>0.20</td></tr><tr><td>Confidence Interval Slope:</td><td>0.911 to 1.001</td></tr><tr><td>Confidence Interval Intercept:</td><td>0.04 to 0.37</td></tr></table>

In-House Matrix Comparison: Serum vs. Plasma $=$ ACE Total Protein Reagent   

<table><tr><td>System</td><td>Range</td><td colspan="2">Results - Serum vs. Plasma</td></tr><tr><td>ACE</td><td rowspan="6">0.5-12.3 g/dL</td><td>Slope:</td><td>1.001</td></tr><tr><td rowspan="5">56 pairs</td><td>Intercept:</td><td>0.12</td></tr><tr><td>Correlation:</td><td>0.9798</td></tr><tr><td>Std. Error Est:</td><td>0.40</td></tr><tr><td>Confidence Interval Slope:</td><td>0.946 to 1.056</td></tr><tr><td>Confidence Interval Intercept:</td><td>-0.24 to 0.48</td></tr><tr><td>ACE Alera</td><td rowspan="5"></td><td>Slope:</td><td>0.999</td></tr><tr><td rowspan="4">0.5-12.0 g/dL 56 pairs</td><td>Intercept:</td><td>0.14</td></tr><tr><td>Correlation:</td><td>0.9840</td></tr><tr><td>Std. Error Est:</td><td>0.35</td></tr><tr><td>Confidence Interval Slope:</td><td>0.950 to 1.047</td></tr><tr><td>ACE Axcel</td><td></td><td>Confidence Interval Intercept:</td><td>-0.18 to 0.46</td></tr><tr><td rowspan="5">81 pairs</td><td rowspan="5">0.5-13.9 g/dL</td><td>Slope:</td><td>0.994</td></tr><tr><td>Intercept:</td><td>0.34</td></tr><tr><td>Correlation:</td><td>0.9885</td></tr><tr><td>Std. Error Est:</td><td>0.26</td></tr><tr><td>Confidence Interval Slope: Confidence Interval Intercept:</td><td>0.961 to 1.028</td></tr></table>

<table><tr><td>Performance Data: In-House Precision Serum vs. Plasma</td></tr></table>

In-House Matrix Comparison: Serum vs. Plasma $=$ ACE Calcium-Aresnazo Reagent   

<table><tr><td>System</td><td>Range</td><td colspan="2">Results - Serum vs. Plasma</td></tr><tr><td>ACE</td><td rowspan="6"></td><td>Slope:</td><td>1.006</td></tr><tr><td rowspan="5">1.0-13.7 mg/dL 56 pairs</td><td>Intercept:</td><td>-0.01</td></tr><tr><td>Correlation:</td><td>0.9824</td></tr><tr><td>Std. Error Est:</td><td>0.39</td></tr><tr><td>Confidence Interval Slope:</td><td>0.955 to 1.058</td></tr><tr><td>Confidence Interval Intercept:</td><td>-0.46 to 0.45</td></tr><tr><td>ACE Alera</td><td rowspan="6"></td><td>Slope:</td><td>1.008</td></tr><tr><td rowspan="5">1.0-13.7 mg/dL</td><td>Intercept:</td><td>-0.06</td></tr><tr><td>Correlation:</td><td>0.9793</td></tr><tr><td>Std. Error Est:</td><td>0.43</td></tr><tr><td>Confidence Interval Slope:</td><td>0.952 to 1.064</td></tr><tr><td>Confidence Interval Intercept:</td><td>-0.55 to 0.42</td></tr><tr><td>ACE Axcel</td><td rowspan="5"></td><td>Slope:</td><td>0.978</td></tr><tr><td rowspan="4">0.7-15.0 mg/dL</td><td>Intercept:</td><td>0.33</td></tr><tr><td>Correlation:</td><td>0.9911</td></tr><tr><td>Std. Error Est:</td><td></td></tr><tr><td></td><td>0.23</td></tr><tr><td rowspan="2"></td><td rowspan="2"></td><td>Confidence Interval Slope:</td><td>0.949 to 1.007</td></tr><tr><td>Confidence Interval Intercept:</td><td>0.06 to 0.60</td></tr></table>

ouse Matrix Comparison: Serum vs. Plasma - ACE Inorganic Phost Reagent   

<table><tr><td>System</td><td>Range</td><td colspan="2">Results - Serum vs. Plasma</td></tr><tr><td>ACE</td><td rowspan="6">1.3-19.3 mg/dL</td><td>Slope:</td><td>1.042</td></tr><tr><td rowspan="5">100 pairs</td><td>Intercept:</td><td>-0.26</td></tr><tr><td>Correlation:</td><td>0.9927</td></tr><tr><td>Std. Error Est:</td><td>0.33</td></tr><tr><td>Confidence Interval Slope:</td><td>1.017 to 1.067</td></tr><tr><td>Confidence Interval Intercept:</td><td>-0.38 to -0.14</td></tr><tr><td>ACE Alera</td><td rowspan="6">1.3-19.3 mg/dL</td><td>Slope:</td><td>1.049</td></tr><tr><td rowspan="5">102 pairs</td><td>Intercept:</td><td>-0.28</td></tr><tr><td>Correlation:</td><td>0.9928</td></tr><tr><td>Std. Error Est:</td><td>0.33</td></tr><tr><td>Confidence Interval Slope:</td><td>1.024 to 1.074</td></tr><tr><td>Confidence Interval Intercept:</td><td>-0.40 to -0.16</td></tr><tr><td>ACE Axcel</td><td rowspan="5"></td><td>Slope:</td><td>0.999</td></tr><tr><td rowspan="4">0.5-19.8 mg/dL 56 pairs</td><td>Intercept:</td><td>0.04</td></tr><tr><td>Correlation:</td><td>0.9950</td></tr><tr><td>Std. Error Est:</td><td></td></tr><tr><td></td><td>0.34</td></tr><tr><td></td><td></td><td>Confidence Interval Slope: Confidence Interval Intercept:</td><td>0.972 to 1.027 -012 to 0.20</td></tr></table>

# POL $=$ Precision for ACE and ACE Alera Clinical Chemistry Systems

Performance Data:   
In-House   
Matrix   
ComparisonSerum vs.   
Plasma

Note: Refer to previously cleared submission k1 13374 for ACE Axcel POL data)

<table><tr><td rowspan=2 colspan=3>Albumin</td><td rowspan=1 colspan=2>ACE Result</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=2>ACE Alera Result</td></tr><tr><td rowspan=1 colspan=2>g/dL SD, %CV</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=2>g/dL SD, %CV</td></tr><tr><td rowspan=1 colspan=1>Lab</td><td rowspan=1 colspan=1>Sample</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Within-Run</td><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Within-Run</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=2 colspan=1>In-House</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>3.5</td><td rowspan=1 colspan=1>0.05</td><td rowspan=1 colspan=1>0.07</td><td rowspan=2 colspan=1>3.5</td><td rowspan=1 colspan=1>0.02</td><td rowspan=1 colspan=1>0.04</td></tr><tr><td rowspan=1 colspan=1>1.4%</td><td rowspan=1 colspan=1>2.0%</td><td rowspan=1 colspan=1>0.6%</td><td rowspan=1 colspan=1>1.1%</td></tr><tr><td rowspan=2 colspan=1>POL 1</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>3.5</td><td rowspan=1 colspan=1>0.04</td><td rowspan=1 colspan=1>0.04</td><td rowspan=2 colspan=1>3.5</td><td rowspan=1 colspan=1>0.05</td><td rowspan=1 colspan=1>0.06</td></tr><tr><td rowspan=1 colspan=1>1.3%</td><td rowspan=1 colspan=1>1.3%</td><td rowspan=1 colspan=1>1.4%</td><td rowspan=1 colspan=1>1.7%</td></tr><tr><td rowspan=2 colspan=1>POL 2</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>3.5</td><td rowspan=1 colspan=1>0.06</td><td rowspan=1 colspan=1>0.07</td><td rowspan=2 colspan=1>3.6</td><td rowspan=1 colspan=1>0.05</td><td rowspan=1 colspan=1>0.05</td></tr><tr><td rowspan=1 colspan=1>1.7%</td><td rowspan=1 colspan=1>2.0%</td><td rowspan=1 colspan=1>1.4%</td><td rowspan=1 colspan=1>1.5%</td></tr><tr><td rowspan=2 colspan=1>POL 3</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>3.5</td><td rowspan=1 colspan=1>0.08</td><td rowspan=1 colspan=1>0.08</td><td rowspan=2 colspan=1>3.5</td><td rowspan=1 colspan=1>0.05</td><td rowspan=1 colspan=1>0.05</td></tr><tr><td rowspan=1 colspan=1>2.3%</td><td rowspan=1 colspan=1>2.4%</td><td rowspan=1 colspan=1>1.6%</td><td rowspan=1 colspan=1>1.6%</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=2 colspan=1>In-House</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>5.0</td><td rowspan=1 colspan=1>0.06</td><td rowspan=1 colspan=1>0.06</td><td rowspan=2 colspan=1>5.0</td><td rowspan=1 colspan=1>0.05</td><td rowspan=1 colspan=1>0.05</td></tr><tr><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.0%</td><td rowspan=1 colspan=1>1.1%</td></tr><tr><td rowspan=2 colspan=1>POL 1</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>4.9</td><td rowspan=1 colspan=1>0.06</td><td rowspan=1 colspan=1>0.07</td><td rowspan=2 colspan=1>5.0</td><td rowspan=1 colspan=1>0.08</td><td rowspan=1 colspan=1>0.09</td></tr><tr><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.4%</td><td rowspan=1 colspan=1>1.7%</td><td rowspan=1 colspan=1>1.9%</td></tr><tr><td rowspan=2 colspan=1>POL 2</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>4.9</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1>0.06</td><td rowspan=2 colspan=1>5.0</td><td rowspan=1 colspan=1>0.06</td><td rowspan=1 colspan=1>0.08</td></tr><tr><td rowspan=1 colspan=1>0.6%</td><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.6%</td></tr><tr><td rowspan=2 colspan=1>POL 3</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>4.9</td><td rowspan=1 colspan=1>0.06</td><td rowspan=1 colspan=1>0.09</td><td rowspan=2 colspan=1>4.9</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1>0.03</td></tr><tr><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.9%</td><td rowspan=1 colspan=1>0.6%</td><td rowspan=1 colspan=1>0.7%</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=2 colspan=1>In-House</td><td rowspan=2 colspan=1>3</td><td rowspan=2 colspan=1>6.2</td><td rowspan=1 colspan=1>0.11</td><td rowspan=1 colspan=1>0.13</td><td rowspan=2 colspan=1>6.2</td><td rowspan=1 colspan=1>0.06</td><td rowspan=1 colspan=1>0.07</td></tr><tr><td rowspan=1 colspan=1>1.9%</td><td rowspan=1 colspan=1>2.1%</td><td rowspan=1 colspan=1>1.0%</td><td rowspan=1 colspan=1>1.1%</td></tr><tr><td rowspan=2 colspan=1>POL 1</td><td rowspan=2 colspan=1>3</td><td rowspan=2 colspan=1>6.1</td><td rowspan=1 colspan=1>0.07</td><td rowspan=1 colspan=1>0.07</td><td rowspan=2 colspan=1>6.2</td><td rowspan=1 colspan=1>0.07</td><td rowspan=1 colspan=1>0.10</td></tr><tr><td rowspan=1 colspan=1>1.1%</td><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.1%</td><td rowspan=1 colspan=1>1.6%</td></tr><tr><td rowspan=2 colspan=1>POL 2</td><td rowspan=2 colspan=1>3</td><td rowspan=2 colspan=1>6.1</td><td rowspan=1 colspan=1>0.10</td><td rowspan=1 colspan=1>0.12</td><td rowspan=2 colspan=1>6.2</td><td rowspan=1 colspan=1>0.06</td><td rowspan=1 colspan=1>0.07</td></tr><tr><td rowspan=1 colspan=1>1.6%</td><td rowspan=1 colspan=1>1.9%</td><td rowspan=1 colspan=1>1.0%</td><td rowspan=1 colspan=1>1.1%</td></tr><tr><td rowspan=2 colspan=1>POL 3</td><td rowspan=2 colspan=1>3</td><td rowspan=2 colspan=1>6.1</td><td rowspan=1 colspan=1>0.10</td><td rowspan=1 colspan=1>0.11</td><td rowspan=2 colspan=1>6.1</td><td rowspan=1 colspan=1>0.08</td><td rowspan=1 colspan=1>0.08</td></tr><tr><td rowspan=1 colspan=1>1.7%</td><td rowspan=1 colspan=1>1.8%</td><td rowspan=1 colspan=1>1.3%</td><td rowspan=1 colspan=1>1.4%</td></tr></table>

<table><tr><td>Performance Data: In-House Matrix Comparison Serum vs. Plasma</td></tr></table>

POL - Precision for ACE and ACE Alera Clinical Chemistry Systems   

<table><tr><td rowspan=3 colspan=3>TotalProtein</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td rowspan=1 colspan=2>ACE Result</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=2>ACE Alera Result</td></tr><tr><td rowspan=1 colspan=2>g/dL SD, %CV</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=2>g/dL SD, %CV</td></tr><tr><td rowspan=1 colspan=1>Lab</td><td rowspan=1 colspan=1>Sample</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Within-Run</td><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Within-Run</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=2 colspan=1>In-House</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>5.3</td><td rowspan=1 colspan=1>0.05</td><td rowspan=1 colspan=1>0.06</td><td rowspan=2 colspan=1>5.3</td><td rowspan=1 colspan=1>0.08</td><td rowspan=1 colspan=1>0.10</td></tr><tr><td rowspan=1 colspan=1>0.9%</td><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.5%</td><td rowspan=1 colspan=1>1.8%</td></tr><tr><td rowspan=2 colspan=1>POL 1</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>5.3</td><td rowspan=1 colspan=1>0.13</td><td rowspan=1 colspan=1>0.13</td><td rowspan=2 colspan=1>5.5</td><td rowspan=1 colspan=1>0.07</td><td rowspan=1 colspan=1>0.10</td></tr><tr><td rowspan=1 colspan=1>2.5%</td><td rowspan=1 colspan=1>2.5%</td><td rowspan=1 colspan=1>1.4%</td><td rowspan=1 colspan=1>1.8%</td></tr><tr><td rowspan=2 colspan=1>POL 2</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>5.3</td><td rowspan=1 colspan=1>0.08</td><td rowspan=1 colspan=1>0.16</td><td rowspan=2 colspan=1>5.2</td><td rowspan=1 colspan=1>0.07</td><td rowspan=1 colspan=1>0.15</td></tr><tr><td rowspan=1 colspan=1>1.5%</td><td rowspan=1 colspan=1>3.1%</td><td rowspan=1 colspan=1>1.3%</td><td rowspan=1 colspan=1>2.8%</td></tr><tr><td rowspan=2 colspan=1>POL 3</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>5.6</td><td rowspan=1 colspan=1>0.10</td><td rowspan=1 colspan=1>0.12</td><td rowspan=2 colspan=1>5.6</td><td rowspan=1 colspan=1>0.07</td><td rowspan=1 colspan=1>0.12</td></tr><tr><td rowspan=1 colspan=1>1.7%</td><td rowspan=1 colspan=1>2.1%</td><td rowspan=1 colspan=1>1.4%</td><td rowspan=1 colspan=1>2.2%</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=2 colspan=1>In-House</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>8.3</td><td rowspan=1 colspan=1>0.10</td><td rowspan=1 colspan=1>0.12</td><td rowspan=2 colspan=1>8.3</td><td rowspan=1 colspan=1>0.10</td><td rowspan=1 colspan=1>0.11</td></tr><tr><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.4%</td><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.4%</td></tr><tr><td rowspan=2 colspan=1>POL 1</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>8.2</td><td rowspan=1 colspan=1>0.08</td><td rowspan=1 colspan=1>0.11</td><td rowspan=2 colspan=1>8.4</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.10</td></tr><tr><td rowspan=1 colspan=1>1.0%</td><td rowspan=1 colspan=1>1.4%</td><td rowspan=1 colspan=1>1.1%</td><td rowspan=1 colspan=1>1.2%</td></tr><tr><td rowspan=2 colspan=1>POL 2</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>8.3</td><td rowspan=1 colspan=1>0.06</td><td rowspan=1 colspan=1>0.18</td><td rowspan=2 colspan=1>8.4</td><td rowspan=1 colspan=1>0.10</td><td rowspan=1 colspan=1>0.11</td></tr><tr><td rowspan=1 colspan=1>0.7%</td><td rowspan=1 colspan=1>2.1%</td><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.4%</td></tr><tr><td rowspan=2 colspan=1>POL 3</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>8.6</td><td rowspan=1 colspan=1>0.04</td><td rowspan=1 colspan=1>0.10</td><td rowspan=2 colspan=1>8.2</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.14</td></tr><tr><td rowspan=1 colspan=1>0.5%</td><td rowspan=1 colspan=1>1.1%</td><td rowspan=1 colspan=1>1.1%</td><td rowspan=1 colspan=1>1.7%</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=2 colspan=1>In-House</td><td rowspan=2 colspan=1>3</td><td rowspan=2 colspan=1>11.2</td><td rowspan=1 colspan=1>0.14</td><td rowspan=1 colspan=1>0.17</td><td rowspan=2 colspan=1>11.3</td><td rowspan=1 colspan=1>0.14</td><td rowspan=1 colspan=1>0.15</td></tr><tr><td rowspan=1 colspan=1>1.3%</td><td rowspan=1 colspan=1>1.5%</td><td rowspan=1 colspan=1>1.3%</td><td rowspan=1 colspan=1>1.4%</td></tr><tr><td rowspan=2 colspan=1>POL 1</td><td rowspan=2 colspan=1>3</td><td rowspan=2 colspan=1>11.2</td><td rowspan=1 colspan=1>0.14</td><td rowspan=1 colspan=1>0.17</td><td rowspan=2 colspan=1>11.3</td><td rowspan=1 colspan=1>0.14</td><td rowspan=1 colspan=1>0.14</td></tr><tr><td rowspan=1 colspan=1>1.3%</td><td rowspan=1 colspan=1>1.5%</td><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.2%</td></tr><tr><td rowspan=2 colspan=1>POL 2</td><td rowspan=2 colspan=1>3</td><td rowspan=2 colspan=1>11.2</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.20</td><td rowspan=2 colspan=1>11.5</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.16</td></tr><tr><td rowspan=1 colspan=1>0.8%</td><td rowspan=1 colspan=1>1.8%</td><td rowspan=1 colspan=1>0.8%</td><td rowspan=1 colspan=1>1.4%</td></tr><tr><td rowspan=2 colspan=1>POL 3</td><td rowspan=2 colspan=1>3</td><td rowspan=2 colspan=1>11.4</td><td rowspan=1 colspan=1>0.22</td><td rowspan=1 colspan=1>0.23</td><td rowspan=2 colspan=1>11.1</td><td rowspan=1 colspan=1>0.26</td><td rowspan=1 colspan=1>0.31</td></tr><tr><td rowspan=1 colspan=1>1.9%</td><td rowspan=1 colspan=1>2.0%</td><td rowspan=1 colspan=1>2.3%</td><td rowspan=1 colspan=1>2.8%</td></tr></table>

<table><tr><td>Performance Data: Precision - POL</td></tr></table>

POL - Precision for ACE and ACE Alera Clinical Chemistry Systems   

<table><tr><td rowspan=2 colspan=3>Calcium-Arsenazo</td><td rowspan=1 colspan=2>ACE Result</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=2>ACE Alera Result</td></tr><tr><td rowspan=1 colspan=2>mg/dL SD, %CV</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=2>mg/dL SD, %CV</td></tr><tr><td rowspan=1 colspan=1>Lab</td><td rowspan=1 colspan=1>Sample</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Within-Run</td><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Within-Run</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=2 colspan=1>In-House</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>7.0</td><td rowspan=1 colspan=1>0.12 SD</td><td rowspan=1 colspan=1>0.17 SD</td><td rowspan=2 colspan=1>6.9</td><td rowspan=1 colspan=1>0.08 SD</td><td rowspan=1 colspan=1>0.15 SD</td></tr><tr><td rowspan=1 colspan=1>1.7</td><td rowspan=1 colspan=1>2.4</td><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>2.1%</td></tr><tr><td rowspan=2 colspan=1>POL 1</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>7.0</td><td rowspan=1 colspan=1>0.14 SD</td><td rowspan=1 colspan=1>0.15 SD</td><td rowspan=2 colspan=1>6.9</td><td rowspan=1 colspan=1>0.07 SD</td><td rowspan=1 colspan=1>0.19 SD</td></tr><tr><td rowspan=1 colspan=1>2.0%</td><td rowspan=1 colspan=1>2.1%</td><td rowspan=1 colspan=1>1.0%</td><td rowspan=1 colspan=1>2.7%</td></tr><tr><td rowspan=2 colspan=1>POL 2</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>7.0</td><td rowspan=1 colspan=1>0.16 SD</td><td rowspan=1 colspan=1>0.17 SD</td><td rowspan=2 colspan=1>7.0</td><td rowspan=1 colspan=1>0.19 SD</td><td rowspan=1 colspan=1>0.19 SD</td></tr><tr><td rowspan=1 colspan=1>2.3%</td><td rowspan=1 colspan=1>2.4%</td><td rowspan=1 colspan=1>2.7%</td><td rowspan=1 colspan=1>2.7%</td></tr><tr><td rowspan=2 colspan=1>POL 3</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>7.0</td><td rowspan=1 colspan=1>0.16 SD</td><td rowspan=1 colspan=1>0.17 SD</td><td rowspan=2 colspan=1>7.0</td><td rowspan=1 colspan=1>0.14 SD</td><td rowspan=1 colspan=1>0.14 SD</td></tr><tr><td rowspan=1 colspan=1>2.3%</td><td rowspan=1 colspan=1>2.4%</td><td rowspan=1 colspan=1>1.9%</td><td rowspan=1 colspan=1>1.9%</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=2 colspan=1>In-House</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>10.7</td><td rowspan=1 colspan=1>0.21 SD</td><td rowspan=1 colspan=1>0.21 SD.</td><td rowspan=2 colspan=1>10.5</td><td rowspan=1 colspan=1>0.05 SD</td><td rowspan=1 colspan=1>0.06 SD</td></tr><tr><td rowspan=1 colspan=1>2.0%</td><td rowspan=1 colspan=1>2.0%</td><td rowspan=1 colspan=1>0.5%</td><td rowspan=1 colspan=1>0.6%</td></tr><tr><td rowspan=2 colspan=1>POL 1</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>10.6</td><td rowspan=1 colspan=1>0.06 SD</td><td rowspan=1 colspan=1>0.06 SD</td><td rowspan=2 colspan=1>10.5</td><td rowspan=1 colspan=1>0.09 SD</td><td rowspan=1 colspan=1>0.33 SD</td></tr><tr><td rowspan=1 colspan=1>0.6%</td><td rowspan=1 colspan=1>0.6%</td><td rowspan=1 colspan=1>0.9%</td><td rowspan=1 colspan=1>3.2%</td></tr><tr><td rowspan=2 colspan=1>POL 2</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>10.5</td><td rowspan=1 colspan=1>0.12 SD</td><td rowspan=1 colspan=1>0.15 SD</td><td rowspan=2 colspan=1>10.6</td><td rowspan=1 colspan=1>0.21 SD</td><td rowspan=1 colspan=1>0.22 SD</td></tr><tr><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.5%</td><td rowspan=1 colspan=1>1.9%</td><td rowspan=1 colspan=1>2.1%</td></tr><tr><td rowspan=2 colspan=1>POL 3</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>10.5</td><td rowspan=1 colspan=1>0.10 SD</td><td rowspan=1 colspan=1>0.11 SD</td><td rowspan=2 colspan=1>10.6</td><td rowspan=1 colspan=1>0.16 SD</td><td rowspan=1 colspan=1>0.16 SD</td></tr><tr><td rowspan=1 colspan=1>1.0%</td><td rowspan=1 colspan=1>1.0%</td><td rowspan=1 colspan=1>1.5%</td><td rowspan=1 colspan=1>1.5%</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=2 colspan=1>In-House</td><td rowspan=2 colspan=1>3</td><td rowspan=2 colspan=1>13.6</td><td rowspan=1 colspan=1>0.11 SD</td><td rowspan=1 colspan=1>0.26 SD</td><td rowspan=2 colspan=1>13.5</td><td rowspan=1 colspan=1>0.17 SD</td><td rowspan=1 colspan=1>0.20 SD</td></tr><tr><td rowspan=1 colspan=1>0.8%</td><td rowspan=1 colspan=1>1.9%</td><td rowspan=1 colspan=1>1.3%</td><td rowspan=1 colspan=1>1.5%</td></tr><tr><td rowspan=2 colspan=1>POL 1</td><td rowspan=2 colspan=1>3</td><td rowspan=2 colspan=1>13.6</td><td rowspan=1 colspan=1>0.14 SD</td><td rowspan=1 colspan=1>0.20 SD</td><td rowspan=2 colspan=1>13.4</td><td rowspan=1 colspan=1>0.14 SD</td><td rowspan=1 colspan=1>0.34 SD</td></tr><tr><td rowspan=1 colspan=1>1.1%</td><td rowspan=1 colspan=1>1.5%</td><td rowspan=1 colspan=1>1.1%</td><td rowspan=1 colspan=1>2.5%</td></tr><tr><td rowspan=2 colspan=1>POL 2</td><td rowspan=2 colspan=1>3</td><td rowspan=2 colspan=1>13.5</td><td rowspan=1 colspan=1>0.32 SD</td><td rowspan=1 colspan=1>0.37 SD</td><td rowspan=2 colspan=1>13.6</td><td rowspan=1 colspan=1>0.21 SD</td><td rowspan=1 colspan=1>0.23 SD</td></tr><tr><td rowspan=1 colspan=1>2.3%</td><td rowspan=1 colspan=1>2.7%</td><td rowspan=1 colspan=1>1.5%</td><td rowspan=1 colspan=1>1.7%</td></tr><tr><td rowspan=2 colspan=1>POL 3</td><td rowspan=2 colspan=1>3</td><td rowspan=2 colspan=1>13.6</td><td rowspan=1 colspan=1>0.16 SD</td><td rowspan=1 colspan=1>0.17 SD</td><td rowspan=2 colspan=1>13.6</td><td rowspan=1 colspan=1>0.14 SD</td><td rowspan=1 colspan=1>0.18 SD</td></tr><tr><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.0%</td><td rowspan=1 colspan=1>1.3%</td></tr></table>

Performance Data:

Precision - POL

POL - Precision for ACE and ACE Alera Clinical Chemistry Systems   

<table><tr><td rowspan=3 colspan=3>InorganicPhosphorusU.V.</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td rowspan=1 colspan=2>ACE Result</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=2>ACE Alera Result</td></tr><tr><td rowspan=1 colspan=2>mg/dL SD, %CV</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=2>mg/dL SD, %CV</td></tr><tr><td rowspan=1 colspan=1>Lab</td><td rowspan=1 colspan=1>Sample</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Within-Run</td><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Within-Run</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=2 colspan=1>In-House</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>2.7</td><td rowspan=1 colspan=1>0.08 SD</td><td rowspan=1 colspan=1>0.08 SD</td><td rowspan=2 colspan=1>2.8</td><td rowspan=1 colspan=1>0.06 SD</td><td rowspan=1 colspan=1>0.06 SD</td></tr><tr><td rowspan=1 colspan=1>3.0%</td><td rowspan=1 colspan=1>3.0%</td><td rowspan=1 colspan=1>2.1%</td><td rowspan=1 colspan=1>2.1%</td></tr><tr><td rowspan=2 colspan=1>POL 1</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>2.7</td><td rowspan=1 colspan=1>0.03 SD</td><td rowspan=1 colspan=1>0.05 SD</td><td rowspan=2 colspan=1>2.7</td><td rowspan=1 colspan=1>0.04 SD</td><td rowspan=1 colspan=1>0.10 SD</td></tr><tr><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.9%</td><td rowspan=1 colspan=1>1.4%</td><td rowspan=1 colspan=1>3.8%</td></tr><tr><td rowspan=2 colspan=1>POL 2</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>2.6</td><td rowspan=1 colspan=1>0.06 SD</td><td rowspan=1 colspan=1>0.09 SD</td><td rowspan=2 colspan=1>2.5</td><td rowspan=1 colspan=1>0.02 SD</td><td rowspan=1 colspan=1>0.11 SD</td></tr><tr><td rowspan=1 colspan=1>2.3%</td><td rowspan=1 colspan=1>3.6%</td><td rowspan=1 colspan=1>0.9%</td><td rowspan=1 colspan=1>4.4%</td></tr><tr><td rowspan=2 colspan=1>POL 3</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>2.8</td><td rowspan=1 colspan=1>0.06 SD</td><td rowspan=1 colspan=1>0.10 SD</td><td rowspan=2 colspan=1>2.9</td><td rowspan=1 colspan=1>0.05 SD</td><td rowspan=1 colspan=1>0.07 SD</td></tr><tr><td rowspan=1 colspan=1>2.1%</td><td rowspan=1 colspan=1>3.5%</td><td rowspan=1 colspan=1>1.9%</td><td rowspan=1 colspan=1>2.4%</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=2 colspan=1>In-House</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>7.0</td><td rowspan=1 colspan=1>0.07 SD</td><td rowspan=1 colspan=1>0.09 SD</td><td rowspan=2 colspan=1>7.1</td><td rowspan=1 colspan=1>0.07 SD</td><td rowspan=1 colspan=1>0.09 SD</td></tr><tr><td rowspan=1 colspan=1>1.0%</td><td rowspan=1 colspan=1>1.3%</td><td rowspan=1 colspan=1>0.9%</td><td rowspan=1 colspan=1>1.3%</td></tr><tr><td rowspan=2 colspan=1>POL 1</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>7.0</td><td rowspan=1 colspan=1>0.04 SD</td><td rowspan=1 colspan=1>0.07 SD</td><td rowspan=2 colspan=1>7.1</td><td rowspan=1 colspan=1>0.07 SD</td><td rowspan=1 colspan=1>0.18 SD</td></tr><tr><td rowspan=1 colspan=1>0.6%</td><td rowspan=1 colspan=1>1.1%</td><td rowspan=1 colspan=1>0.9%</td><td rowspan=1 colspan=1>2.5%</td></tr><tr><td rowspan=2 colspan=1>POL 2</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>6.7</td><td rowspan=1 colspan=1>0.08 SD</td><td rowspan=1 colspan=1>0.14 SD</td><td rowspan=2 colspan=1>6.7</td><td rowspan=1 colspan=1>0.07 SD</td><td rowspan=1 colspan=1>0.22 SD</td></tr><tr><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>2.1%</td><td rowspan=1 colspan=1>1.1%</td><td rowspan=1 colspan=1>3.2%</td></tr><tr><td rowspan=2 colspan=1>POL 3</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>7.2</td><td rowspan=1 colspan=1>0.04 SD</td><td rowspan=1 colspan=1>0.07 SD</td><td rowspan=2 colspan=1>7.4</td><td rowspan=1 colspan=1>0.10 SD</td><td rowspan=1 colspan=1>0.13 SD</td></tr><tr><td rowspan=1 colspan=1>0.6%</td><td rowspan=1 colspan=1>1.0%</td><td rowspan=1 colspan=1>1.4%</td><td rowspan=1 colspan=1>1.7%</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=2 colspan=1>In-House</td><td rowspan=2 colspan=1>3</td><td rowspan=2 colspan=1>11.1</td><td rowspan=1 colspan=1>0.14 SD</td><td rowspan=1 colspan=1>0.18 SD</td><td rowspan=2 colspan=1>11.3</td><td rowspan=1 colspan=1>0.09 SD</td><td rowspan=1 colspan=1>0.11 SD</td></tr><tr><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.6%</td><td rowspan=1 colspan=1>0.8%</td><td rowspan=1 colspan=1>0.9%</td></tr><tr><td rowspan=2 colspan=1>POL 1</td><td rowspan=2 colspan=1>3</td><td rowspan=2 colspan=1>11.1</td><td rowspan=1 colspan=1>0.13 SD</td><td rowspan=1 colspan=1>0.14 SD</td><td rowspan=2 colspan=1>11.3</td><td rowspan=1 colspan=1>0.16 SD</td><td rowspan=1 colspan=1>0.27 SD</td></tr><tr><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.3%</td><td rowspan=1 colspan=1>1.4%</td><td rowspan=1 colspan=1>2.4%</td></tr><tr><td rowspan=2 colspan=1>POL 2</td><td rowspan=2 colspan=1>3</td><td rowspan=2 colspan=1>10.9</td><td rowspan=1 colspan=1>0.12 SD</td><td rowspan=1 colspan=1>0.21 SD</td><td rowspan=2 colspan=1>10.6</td><td rowspan=1 colspan=1>0.15 SD</td><td rowspan=1 colspan=1>0.21 SD</td></tr><tr><td rowspan=1 colspan=1>1.1%</td><td rowspan=1 colspan=1>1.9%</td><td rowspan=1 colspan=1>1.4%</td><td rowspan=1 colspan=1>1.9%</td></tr><tr><td rowspan=2 colspan=1>POL 3</td><td rowspan=2 colspan=1>3</td><td rowspan=2 colspan=1>11.4</td><td rowspan=1 colspan=1>0.13 SD</td><td rowspan=1 colspan=1>0.18 SD</td><td rowspan=2 colspan=1>11.7</td><td rowspan=1 colspan=1>0.11 SD</td><td rowspan=1 colspan=1>0.14 SD</td></tr><tr><td rowspan=1 colspan=1>1.1%</td><td rowspan=1 colspan=1>1.6%</td><td rowspan=1 colspan=1>0.9%</td><td rowspan=1 colspan=1>1.2%</td></tr></table>

<table><tr><td colspan="1" rowspan="6">PerformanceData:Precision-POL</td><td colspan="5" rowspan="1">POL - Method Comparison for ACE Clinical Chemistry System</td></tr><tr><td colspan="1" rowspan="1">Reagent</td><td colspan="1" rowspan="1">Statistic</td><td colspan="1" rowspan="1">ACE In-House(x)vs.ACEPOL 1 (y)</td><td colspan="1" rowspan="1">ACE In-House(x) vs.ACEPOL 2(y)</td><td colspan="1" rowspan="1">ACE In-House(x)vs.ACEPOL 3(y)</td></tr><tr><td colspan="1" rowspan="1">Albumin</td><td colspan="1" rowspan="1">nRange (g/dL)RegressionCorrelationStd. Error Est.Cl SlopeCI Intercept</td><td colspan="1" rowspan="1">501.0 to 6.4y = 0.983x + 0.030.99340.100.950 to 1.016-0.11 to 0.17</td><td colspan="1" rowspan="1">501.0 to 6.4y = 0.992x - 0.010.99650.080.968 to 1.016-0.11 to 0.09</td><td colspan="1" rowspan="1">501.0 to 6.4y = 1.006x - 0.030.99710.070.984 to 1.028-0.12 to 0.06</td></tr><tr><td colspan="1" rowspan="1">Total Protein</td><td colspan="1" rowspan="1">nRange (g/dL)RegressionCorrelationStd. Error Est.Cl SlopeCI Intercept</td><td colspan="1" rowspan="1">510.9 to 13.6y = 1.008x + 0.020.99570.150.981 to 1.035-0.17 to 0.22</td><td colspan="1" rowspan="1">510.9 to 13.6y = 1.007x + 0.060.99760.110.987 to 1.027-0.08 to 0.20</td><td colspan="1" rowspan="1">510.9 to 13.6y = 1.029x + 0.010.99600.151.003 to 1.056-0.18 to 0.20</td></tr><tr><td colspan="1" rowspan="1">Calcium-Arsenazo</td><td colspan="1" rowspan="1">nRange (mg/dL)RegressionCorrelation Std.Error Est. ClSlopeCl Intercept</td><td colspan="1" rowspan="1">501.9 to 13.7y= 1.004x - 0.070.99150.260.966 to 1.042-0.42 to 0.27</td><td colspan="1" rowspan="1">501.9 to 13.7y= 1.002x -0.170.99440.210.971 to 1.033-0.45 to 0.11</td><td colspan="1" rowspan="1">501.9 to 13.7y= 0.981 x + 0.090.99510.190.953 to 1.009-0.17 to 0.34</td></tr><tr><td colspan="1" rowspan="1">InorganicPhosphorusU.V.</td><td colspan="1" rowspan="1">nRange (mg/dL)RegressionCorrelation Std.Error Est. ClSlopeCl Intercept</td><td colspan="1" rowspan="1">501.0 to 18.4y = 0.966x + 0.130.99910.120.954 to 0.9780.07 to 0.19</td><td colspan="1" rowspan="1">481.0 to 18.4y=1.007x-0.100.99820.160.989 to 1.025-0.18 to -0.01</td><td colspan="1" rowspan="1">501.0 to 18.4y= 0.975x +0.110.99870.140.960 to 0.9890.04 to 0.19</td></tr><tr><td colspan="1" rowspan="6">PerformanceData:Precision-POL</td><td colspan="5" rowspan="1">POL = Method Comparison for ACE Alera Clinical Chemistry System</td></tr><tr><td colspan="1" rowspan="1">Reagent</td><td colspan="1" rowspan="1">Statistic</td><td colspan="1" rowspan="1">ACE In-House (x)VS. ACEAlera POL1 (y)</td><td colspan="1" rowspan="1">ACE In-House(x)vs.ACE AleraPOL 2(y)</td><td colspan="1" rowspan="1">ACE In-House(x) vs.ACE AleraPOL3 (y)</td></tr><tr><td colspan="1" rowspan="1">Albumin</td><td colspan="1" rowspan="1">nRange (g/dL)RegressionCorrelationStd. Error Est.Cl SlopeCl Intercept</td><td colspan="1" rowspan="1">501.0 to 6.4y = 1.004x - 0.030.99490.090.975 to 1.034-0.15 to 0.10</td><td colspan="1" rowspan="1">501.0 to 6.4y= 1.005x -0.050.99600.080.979 to 1.03 1-0.16 to 0.06</td><td colspan="1" rowspan="1">501.0 to 6.4y = 0.982x + 0.010.99670.070.959 to 1.005-0.09 to 0.11</td></tr><tr><td colspan="1" rowspan="1">Total Protein</td><td colspan="1" rowspan="1">nRange (g/dL)RegressionCorrelationStd. Error Est.Cl SlopeCI Intercept</td><td colspan="1" rowspan="1">510.9 to 13.6y = 0.998x + 0.160.99690.130.976 to 1.0200.00 to 0.33</td><td colspan="1" rowspan="1">510.9 to 13.6y = 1.027x - 0.060.99620.141.002 to 1.053-0.24 to 0.13</td><td colspan="1" rowspan="1">510.9 to 13.6y= 0.979x + 0.240.99640.140.955 to 1.0030.07 to 0.42</td></tr><tr><td colspan="1" rowspan="1">Calcium-Arsenazo</td><td colspan="1" rowspan="1">nRange (mg/dL)RegressionCorrelation Std.Error Est. ClSlopeCI Intercept</td><td colspan="1" rowspan="1">501.9 to 13.7y = 0.992x - 0.090.99040.270.952 to 1.032-0.46 to 0.27</td><td colspan="1" rowspan="1">501.9 to 13.7y = 1.007x-0.110.99290.230.972 to 1.042-0.43 to 0.21</td><td colspan="1" rowspan="1">501.9 to 13.7y = 1.008x - 0.080.99290.230.973 to 1.043-0.40 to 0.23</td></tr><tr><td colspan="1" rowspan="1">InorganicPhosphorusU.V.</td><td colspan="1" rowspan="1">nRange (mg/dL)RegressionCorrelation Std.Error Est. ClSlopeCl Intercept</td><td colspan="1" rowspan="1">501.0 to 18.4y= 1.015x+0.140.99920.121.003 to 1.0270.08 to 0.20</td><td colspan="1" rowspan="1">501.0 to 18.4y = 0.960x + 0.120.99860.140.945 to 0.9740.05 to 0.19</td><td colspan="1" rowspan="1">501.0 to 18.4y= 0.984x +0.050.99910.120.972 to 0.996-0.01 to 0.11</td></tr></table>

Performance Data:

# Performance data for the Alfa Wassermann ACE Reagents run on the Alfa Wassermann ACE Alera Clinical Chemistry Systems

Method Comparison - POL on ACE   
Detection Limits - ACE Alera Clinical Chemistry System   

<table><tr><td rowspan=1 colspan=1>ACE Alera</td><td rowspan=1 colspan=1>ALB(g/dL)</td><td rowspan=1 colspan=1>TP(g/dL)</td><td rowspan=1 colspan=1>CA(mg/dL)</td><td rowspan=1 colspan=1>PHOS(mg/dL)</td></tr><tr><td rowspan=1 colspan=1>LoB</td><td rowspan=1 colspan=1>0.08</td><td rowspan=1 colspan=1>0.08</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.25</td></tr><tr><td rowspan=1 colspan=1>LoD</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.13</td><td rowspan=1 colspan=1>0.11</td><td rowspan=1 colspan=1>0.35</td></tr><tr><td rowspan=1 colspan=1>LoQ</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.20</td><td rowspan=1 colspan=1>0.23</td><td rowspan=1 colspan=1>0.35</td></tr></table>

Linearity - ACE Alera Clinical Chemistry System   

<table><tr><td rowspan=1 colspan=1>ACEReagents</td><td rowspan=1 colspan=1>Low LevelTested</td><td rowspan=1 colspan=1>Upper LevelTested</td><td rowspan=1 colspan=1>Linear to:</td><td rowspan=2 colspan=1>Linear RegressionEquationy= 0.980x + 0.01r2=0.9982</td></tr><tr><td rowspan=1 colspan=1>ALB</td><td rowspan=1 colspan=1>0.1 g/dL</td><td rowspan=1 colspan=1>7.6 g/dL</td><td rowspan=1 colspan=1>7.6 g/dL</td></tr><tr><td rowspan=1 colspan=1>TP</td><td rowspan=1 colspan=1>0.2 g/dL</td><td rowspan=1 colspan=1>15.1 g/dL</td><td rowspan=1 colspan=1>15.1 g/dL</td><td rowspan=1 colspan=1>y= 0.991x + 0.04r2 = 0.9979</td></tr><tr><td rowspan=1 colspan=1>CA</td><td rowspan=1 colspan=1>0.3 g/dL</td><td rowspan=1 colspan=1>16.5 mg/dL</td><td rowspan=1 colspan=1>16.5 mg/dL</td><td rowspan=1 colspan=1>y= 0.992x + 0.27r2 = 0.9990</td></tr><tr><td rowspan=1 colspan=1>PHOS</td><td rowspan=1 colspan=1>0.2 mg/dL</td><td rowspan=1 colspan=1>21 mg/dL</td><td rowspan=1 colspan=1>21 mg/dL</td><td rowspan=1 colspan=1>y= 1.001x + 0.03r2 = 0.9995</td></tr></table>

Performance Data:

ACE Alera

Interferences - ACE Alera Clinical Chemistry System   

<table><tr><td rowspan=2 colspan=1>Interferentson ACE Alera</td><td rowspan=1 colspan=4>No Significant Interference at or below:</td></tr><tr><td rowspan=1 colspan=1>ALB</td><td rowspan=1 colspan=1>TP</td><td rowspan=1 colspan=1>CA</td><td rowspan=1 colspan=1>PHOS</td></tr><tr><td rowspan=1 colspan=1>Icterus</td><td rowspan=1 colspan=1>60 mg/dL</td><td rowspan=1 colspan=1>56.8 mg/dL</td><td rowspan=1 colspan=1>58.8 mg/dL</td><td rowspan=1 colspan=1>11.5 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Hemolysis</td><td rowspan=1 colspan=1>250 mg/dL</td><td rowspan=1 colspan=1>250 mg/dL</td><td rowspan=1 colspan=1>1000 mg/dL</td><td rowspan=1 colspan=1>250 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Lipemia</td><td rowspan=1 colspan=1>1000 mg/dL</td><td rowspan=1 colspan=1>929 mg/dL</td><td rowspan=1 colspan=1>1000 mg/dL</td><td rowspan=1 colspan=1>306 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>6 mg/dL</td><td rowspan=1 colspan=1>6 mg/dL</td><td rowspan=1 colspan=1>6 mg/dL</td><td rowspan=1 colspan=1>6 mg/dL</td></tr></table>

Precision - ACE Alera Clinical Chemistry System   

<table><tr><td rowspan=2 colspan=2>on-ACE Alera</td><td rowspan=1 colspan=3>Precision (SD, %CV)</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Within-Run</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=3 colspan=1>ALBg/dL</td><td rowspan=1 colspan=1>SerumLow</td><td rowspan=1 colspan=1>2.6</td><td rowspan=1 colspan=1>0.03, 1.3%</td><td rowspan=1 colspan=1>0.05, 2.0%</td></tr><tr><td rowspan=1 colspan=1>SerumMid</td><td rowspan=1 colspan=1>3.4</td><td rowspan=1 colspan=1>0.07, 1.9%</td><td rowspan=1 colspan=1>0.09, 2.5%</td></tr><tr><td rowspan=1 colspan=1>SerumHigh</td><td rowspan=1 colspan=1>4.3</td><td rowspan=1 colspan=1>0.03, 0.7%</td><td rowspan=1 colspan=1>0.10, 2.3%</td></tr><tr><td rowspan=3 colspan=1>CAmg/dL</td><td rowspan=1 colspan=1>SerumLow</td><td rowspan=1 colspan=1>6.5</td><td rowspan=1 colspan=1>0.08, 1.3%</td><td rowspan=1 colspan=1>0.13, 2.1%</td></tr><tr><td rowspan=1 colspan=1>SerumMid</td><td rowspan=1 colspan=1>9.8</td><td rowspan=1 colspan=1>0.12, 1.2%</td><td rowspan=1 colspan=1>0.22, 2.3%</td></tr><tr><td rowspan=1 colspan=1>SerumHigh</td><td rowspan=1 colspan=1>12.6</td><td rowspan=1 colspan=1>0.23, 1.8%</td><td rowspan=1 colspan=1>0.29, 2.3%</td></tr><tr><td rowspan=3 colspan=1>TPg/dL</td><td rowspan=1 colspan=1>SerumLow</td><td rowspan=1 colspan=1>4.2</td><td rowspan=1 colspan=1>0.10, 2.3%</td><td rowspan=1 colspan=1>0.11, 2.6%</td></tr><tr><td rowspan=1 colspan=1>SerumMid</td><td rowspan=1 colspan=1>6.8</td><td rowspan=1 colspan=1>0.09, 1.3%</td><td rowspan=1 colspan=1>0.14, 2.1%</td></tr><tr><td rowspan=1 colspan=1>SerumHigh</td><td rowspan=1 colspan=1>10.1</td><td rowspan=1 colspan=1>0.23, 2.3%</td><td rowspan=1 colspan=1>0.32, 3.1%</td></tr><tr><td rowspan=3 colspan=1>PHOSmg/dL</td><td rowspan=1 colspan=1>SerumLow</td><td rowspan=1 colspan=1>2.0</td><td rowspan=1 colspan=1>0.04, 2.3%</td><td rowspan=1 colspan=1>0.11, 5.7%</td></tr><tr><td rowspan=1 colspan=1>SerumMid</td><td rowspan=1 colspan=1>3.8</td><td rowspan=1 colspan=1>0.12, 3.2%</td><td rowspan=1 colspan=1>0.16, 4.2%</td></tr><tr><td rowspan=1 colspan=1>SerumHigh</td><td rowspan=1 colspan=1>6.5</td><td rowspan=1 colspan=1>0.17, 2.5%</td><td rowspan=1 colspan=1>0.24, 3.6%</td></tr></table>

Performance Data: ACE Alera

Method Comparison - ACE Alera Clinical Chemistry System   

<table><tr><td rowspan=2 colspan=5>In-House ACE (x) versus In-House ACE Alera (y)ALB              TP              CA            PHOS</td></tr><tr><td rowspan=1 colspan=1>TP</td><td rowspan=1 colspan=1>CA</td></tr><tr><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>56</td><td rowspan=1 colspan=1>55</td><td rowspan=1 colspan=1>55</td></tr><tr><td rowspan=1 colspan=1>Range</td><td rowspan=1 colspan=1>1.0 - 6.4 g/dL</td><td rowspan=1 colspan=1>0.2 - 13.6 g/dL</td><td rowspan=1 colspan=1>[0.2 - 13.7 mg/dL</td><td rowspan=1 colspan=1>0.2 -18.4 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>1.005</td><td rowspan=1 colspan=1>1.009</td><td rowspan=1 colspan=1>0.991</td><td rowspan=1 colspan=1>1.006</td></tr><tr><td rowspan=1 colspan=1>Intercept</td><td rowspan=1 colspan=1>-0.03</td><td rowspan=1 colspan=1>-0.01</td><td rowspan=1 colspan=1>-0.02</td><td rowspan=1 colspan=1>-0.01</td></tr><tr><td rowspan=1 colspan=1>CorrelationCoefficient</td><td rowspan=1 colspan=1>0.9961</td><td rowspan=1 colspan=1>0.9988</td><td rowspan=1 colspan=1>0.9990</td><td rowspan=1 colspan=1>0.9994</td></tr><tr><td rowspan=1 colspan=1>Std. Error</td><td rowspan=1 colspan=1>0.08</td><td rowspan=1 colspan=1>0.12</td><td rowspan=1 colspan=1>0.13</td><td rowspan=1 colspan=1>0.10</td></tr><tr><td rowspan=1 colspan=1>CI Slope</td><td rowspan=1 colspan=1>0.979 to 1.030</td><td rowspan=1 colspan=1>0.995 to 1.022</td><td rowspan=1 colspan=1>0.979 to 1.003</td><td rowspan=1 colspan=1>0.997 to 1.016</td></tr><tr><td rowspan=1 colspan=1>CI Intercept</td><td rowspan=1 colspan=1>-0.13 to 0.08</td><td rowspan=1 colspan=1>-0.10 to 0.08</td><td rowspan=1 colspan=1>-0.13 to 0.08</td><td rowspan=1 colspan=1>-0.06 to 0.03</td></tr></table>

# August 19, 2013

Alfa Wassermann Diagnostic Technologies, LLC C/O Hyman Katz, Ph.D.   
4 Henderson Drive   
WEST CALDWELL NJ 07006

Re: K131488 Trade/Device Name: ACE Albumin Reagent ACE Total Protein Reagent ACE Calcium-Arsenazo Reagent ACE Inorganic Phosphorus U.V. Reagent Regulation Number: 21 CFR 862.1035 Regulation Name: Albumin test system Regulatory Class: II Product Code: CIX, CEK, CJY, CEO Dated: July 17, 2013 Received: July 18, 2013

Dear Dr. Katz:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to evi that have beeecassi rance wit h rovisions   deal FoodDru and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties.We remind you, however, that device labeling must be truthful and not misledng.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://wwv.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm1 15809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to   
http://www.fda.gov/MedicalDevices/Salcty/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarkct Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Intermet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

# Carol C. Benson -S for

Courtney H. Lias, Ph.D.   
Director   
Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostics   
and Radiological Health   
Center for Devices and Radiological Health

# Indications for Use

510(k) Number (if known): k131488

Device Name: ACE Albumin Reagent

Indications for Use:

ACE Albumin Reagent is intended for the quantitative determination of albumin concentration in serum and lithium heparin plasma using the ACE, ACE Alera and ACE Axcel Clinical Chcmistry Systems. Albumin measurements are used in the diagnosis and treatment of numerous diseases involving primarily the liver or kidneys. This test is intended for use in clinical laboratories or physician office laboratories. For in vitro diagnostic use only.

Device Name: ACE Total Protein Reagent

Indications for Use:

ACE Total Protcin Reagent is intended for the quantitative determination of total protein concentration in serum and lithium heparin plasma using the ACE, ACE Alera and ACE Axcel Clinical Chemistry Systems. Total protein measurements are used in the diagnosis and trcatment of a variely of discases involving the liver, kidney, or bone marrow as well as other metabolic or nutritional disorders. This test is intended for use in clinical laboratories or physician office laboratories. For in viltro diagnostic use only.

# Concurrence of CDRH, Office of In Vitro Devices or Radiological Health (OIR)

Ruth A. Chesler -S

# Indications for Use

510(k) Number (if known): k131488

Device Name: ACE Calcium-Arsenazo Reagent

Indications for Use: ACE Calcium-Arsenazo Reagent is intended for the quantitative determination of calcium concentration in serum and lithium beparin plasma using the ACE, ACE Alera and ACE Axcel Clinical Chemistry Systems. Calcium measurements are used in the diagnosis and treatment of parathyroid disease, a variety of bone diseases, chronic renal disease and tetany (intermittent muscular contractions or spasms). This test is intended for use in clinical laboratories or physician office laboratories. For in vitro diagnostic use only.

Device Name: ACE Inorganic Phosphorus U.V. Reagent

Indications for Use: ACE Inorganic Phosphorus U.V. Reagent is intended for the quantitative determination of inorganic phosphorus concentration in serum and lithium heparin plasma using the ACE, ACE Alera and ACE Axcel Clinical Chemistry Systems. Measurements of inorganic phosphorus are used in the diagnosis and treatment of various disorders, including parathyroid gland and kidney diseases and vitamin D imbalance. This test is intended for use in clinical laboratories or physician office laboratories. For in vitro diagnostic use only.

Ruth A. Chesler -S